Abstract
Viral and fungal infections and some cancers may be described as diseases that are characterized by the expression of certain unwanted proteins. They could be termed induced genetic disorders, with induction provided by mutation or infection. A comprehensive method to inactivate injurious genes based on their nucleic acid sequences has the potential to provide effective antiviral and anticancer agents with greatly reduced side effects. We describe a chemical approach to such gene-specific pharmaceutical agents. Our initial efforts have been to develop new chemical reagents that can carry out catalytic destruction of specific mRNA sequences. We chose hydrolysis as a chemical means of destruction, because hydrolysis is compatible with living cells. Our sequence-specific catalytic RNA hydrolysis reagents may be described as functional ribozyme mimics. Reactivity is provided by small-molecule catalysts, such as metal complexes. Specificity is provided by oligonucleotide probes. Here we report initial results on the sequence-specific, hydrolytic cleavage of mRNA from the HIVgag gene, using a ribozyme mimic. The reagent is composed of a terpyridylCu(II) complex for cleavage activity and an oligonucleotide for sequence specificity.
Similar content being viewed by others
Notes and References
Uhlmann, E. and Peyman, A. (1990),Chem. Rev. 90, 544.
Cohen, J. S. ed., (1989),Oligodeoxynucleotides: Antisense Inhibitors of Gene Expression, CRC Press, Boca Raton, FL.
Stein, C.A. and Cohen, J. S. (1988),Cancer Res. 48, 2659–2668.
For a review,see Green, P. J. et al. (1986),Ann. Rev. Biochem. 55, 569.
Heywood, S. M. (1986),Nucleic Acids Res. 14, 6771.
Izant, J. G. and Weintraub, H. (1985),Science 229, 345.
Zamecnik, P. C. and Stephenson, M. L. (1978),Proc. Natl. Acad. Sci. USA 75, 280
Stephenson, M. L. and Zamecnik, P. C. (1978),Proc. Natl. Acad. Sci. USA 75, 285.
Representative examples: Matsukura, M., Shinozuka, K., Zon, G., Mitsuya, H., Reitz, M., Cohen, J. S., and Broder, S. (1987),Proc. Natl. Acad. Sci. USA 84, 7706
Goodchild, J. et al. (1988),Proc. Natl. Acad. Sci. USA 85, 5507.
Miller, P. S., Agris, C. H., Aurelian, L., Blake K. R., Murakami, A., Reddy, M. P., Spitz, S. A., and Ts’O, P. O. P. (1985),Biochemie 67, 769.
Bashkin, J. K., Stern, M. K., and Modak, A. S. RNA Hydrolysis, patent applied for, 6/90.
Bashkin, J. K., Modak, A. S., and Stern, M. K., RNA Hydrolysis, European patent EP 533753, World patent WO 9119730.
Stern, M. K., Bashkin, J. K., and Sall, E. D. (1990),J. Am. Chem. Soc. 112, 5357–5359.
Bashkin, J. K., Gard, J. K., and Modak, A. S. (1990),J. Org. Chem. 55, 5125–5132.
Modak, A. S., Gard, J. K., Merriman, M. C., Winkeler, K. A., Bashkin, J. K., and Stern, M. K. (1991),J. Am. Chem. Soc. 113, 283–291.
Bashkin, J. K., McBeath, R. J., Modak, A. S., Sample, K. R., and Wise, W. B. (1991),J. Org. Chem. 56, 3168–3176.
Bashkin, J. K. (1993, inBioinorganic Chemistry of Copper, Karlin, K. and Tyeklar, Z., eds., Chapman and Hall, New York, pp. 132–139.
Bashkin, J. K., Sondhi, S. M., Sampath, U., d’Avignon, D. A., and Modak, A. S. (1994),New J. Chem. 18, 305–316.
Bashkin, J. K. and Jenkins, L. A. (1993),J. Chem. Soc. Dalton Trans. 3631–3632.
Bashkin, J. K. and Jenkins, L. A. (1994),Comments Inorg. Chem. 16, 77–93.
Bashkin, J. K., Frolova, E. I., and Sampath, U. (1994),J. Am. Chem. Soc. 116, 5981,5982.
Haselhoff, J. and Gerlach, W. L. (1988),Nature 334, 585–591.
Cech, T. R. (1988),J. Am. Med. Assoc. 260, 3030–3034.
Cech, T. R. (1987),Science 236, 1532–1539.
Altman, S. (1990),Angew. Chem. Int. Ed. Engl. 29, 749–758.
For a recent overview,see Chrisey, L., Rossi, J., and Sarver, N. (1991),Antisense Res. and Dev. 1, 57–63.
Jeffries, A. C. and Symons, R. H. (1989),Nucleic Acid Res. 17, 1371–1377.
Zuag, A. J., Kent, J. R., and Cech, T. R. (1984),Science 224, 574–578.
Sigman, D. S. (1986),Acc. Chem. Res. 19, 180–186.
Chen, C.-H. B. and Sigman, D. S. (1986),Proc. Natl. Acad. Sci. USA 83, 7147–7151.
Chen, C.-H. B. and Sigman, D. S. (1988),J. Am. Chem. Soc. 110, 6570–6572.
Chu, B. C. F. and Orgel, L. E. (1985),Proc. Natl. Acad. Sci. USA 82, 963–967.
Dervan, P. B. (1986),Science 232, 464–471.
Dreyer, G. B. and Dervan, P. B. (1985),Proc. Natl. Acad. Sci, USA 82, 968–972.
Barton, J. K. (1986),Science 233, 727–734.
Tullius, T. D. and Dombroski, B. A. (1986),Proc. Natl. Acad. Sci. USA 83, 5469–5473.
Hecht, S. M., ed. (1979),Bleomycin: Chemical, Biochemical, and Biological Aspects. New York: Springer-Verlag.
Kozarich, J. W., Worth, L., Jr., Frank, B. L., Christner, D., Vanderwall, D. E., and Stubbe, J. (1989),Science 245, 1396.
Sugano, Y., Kittaka, A., Otsuka, M., Ohno, M., Sugiura, Y., and Umezawa, H. (1986),let. Lett. 27, 3631–3634.
Delany, K., Arora, S. K., and Mascharak, P. K. (1988),Inorg. Chem. 27, 705–712.
Breslow, R., Huang, D-L., and Anslyn, E. (1989),Proc. Natl. Acad. Sci. USA 86, 1746–1750.
Anslyn, E. and Breslow, R. (1989),J. Am. Chem. Soc. 111, 4473–4482.
Anslyn, E. and Breslow, R. (1989),J. Am. Chem. Soc. 111, 5972–5973.
Farkas, W. (1968),Biochim. Biophys. Acta. 155, 401–409.
Butzow, J. J. and Eichhorn, G. (1971),Biochemistry 10, 2019–2027.
Butzow, J. J. and Eichhorn, G. (1975),Nature 254, 358–369.
Ikenaga, H. and Inoue, Y. (1974),Biochemistry 13, 577–582.
Brown, R. S., Dewan, J. C., and Klug, A. (1985),Biochemistry 24, 4785–4801.
Behlen, L. S., Sampson, J. R., Direnzo, A. B., and Uhlenbeck, O. C. (1990),Biochemistry 29, 2513–2523.
Dimroth, K., Witzel, H., Hulsen, W., and Mirbach, H. (1959),Annalen 620, 94–108.
Bergstrom, D. E. and Ogawa, M. K. (1978),J. Am. Chem. Soc. 100, 8106.
Dreyer, G. B. and Dervan, P. B. (1985),Proc. Natl. Acad. Sci. USA 82, 968.
Celander, D. W. and Cech, T. R. (1990),Biochemistry 29, 1355.
Westheimer, F. H. (1987),Science 235, 1173.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bashkin, J.K., Sampath, U. & Frolova, E. Ribozyme mimics as catalytic antisense reagents. Appl Biochem Biotechnol 54, 43–56 (1995). https://doi.org/10.1007/BF02787910
Issue Date:
DOI: https://doi.org/10.1007/BF02787910